BPC-157 was shown to reduce gastrointestinal inflammation by reducing the production of reactive oxygen species
This is why I only recommend companies with third-party testing, transparent manufacturing, and established reputations
The committee will review seven peptides, including BPC-157, TB-500, KPV, and MOTS-c, for possible inclusion on the Section 503A Bulks List, the list that determines which bulk substances licensed pharmacies and physicians may legally compound
Documented interactions with dopaminergic, serotonergic, GABAergic, and prostaglandin systems in animal models
Sources & References: Frequently Asked Questions About BPC-157 Common questions from researchers buying BPC-157 for laboratory studies